Home > Riviste > Minerva Ginecologica > Fascicoli precedenti > Articles online first > Minerva Ginecologica 2017 Mar 07

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

MINERVA GINECOLOGICA

Rivista di Ostetricia e Ginecologia


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index


eTOC

 

Minerva Ginecologica 2017 Mar 07

DOI: 10.23736/S0026-4784.17.04041-2

Copyright © 2017 EDIZIONI MINERVA MEDICA

lingua: Inglese

Contraception for women with heart disease: an update

Rogério BONASSI MACHADO 1 , Ana C. GANDOLPHO 1, Narayana SANTANA 1, Rogerio C. BOCARDO 1, Nathalia PALANDRI 1, Renato MORASSUTTI MACHADO 2

1 Department of Gynecology and Obstetrics, Jundiaí Medical School, Jundiaí, São Paulo, Brazil; 2 University of Sao Caetano do Sul, Faculty of Medicine, São Paulo, Brazil


PDF  


There is a lack of studies dealing specifically with contraceptive use in women with heart disease. This may generate doubts in professionals counseling on the patient’s risk of pregnancy as a function of her cardiomyopathy. Moreover, uncertainties may arise with respect to the optimal contraceptive choice for each individual case. In view of the increasing number of women of reproductive age with cardiac disease, this review aims at providing practical guidance for clinicians, including cardiolo- gists, obstetricians, general practitioners and family planning specialists, with regards to safe contraceptive choices and counseling on the risk of pregnancy in women with heart disease.


KEY WORDS: Contraception - Combined oral contraceptives - Progestogen-only contraception - Heart disease - Congenital heart disease - Preconception counseling

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail

rogeriobonassi@terra.com.br